The country has blazed a trail in Africa with the Nigeria Centre for Disease Control (NCDC) successfully validating the first phase of the viral Ribonucleic Acid (RNA) extraction which should enable local production of cheap testing kits for coronavirus.
![](https://thenigerialawyer.com/wp-content/uploads/2026/09/2026-IDRI-Masterclass.png")
The validation took place on Thursday in the laboratory of the National Biotechnology Development Agency (NABDA) in Abuja.
The Director-General of NABDA, Prof. Alex Akpa, told the News Agency of Nigeria (NAN) after the exercise that the success of the validation was important not only to Nigeria but Africa as a whole.
“The success of this validation shall enable us to massively produce test kits so that more people would be tested for COVID-19, not only in Nigeria but in Africa.
“The immediate aim is to produce reagents for real time Polymerase Chain Reaction (PCR), and remember, recently the lack of reagents stalled work in Kano and molecular diagnosis could no longer take place,’’ Akpa said.
He also recalled that the absence of the same reagent equally stalled COVID-19 diagnosis in Lagos for many days.
“This project is, therefore, designed to enable not only Nigeria but the whole of Africa to put the issue of shortage of reagents behind,’’ the director-general said.
[A MUST HAVE] Evidence Act Demystified With Recent And Contemporary Cases And Materials
Available now for NGN 40,000 at ASC Publications, 10, Boyle Street, Onikan, Lagos. Beside High Court, TBS. Email publications@ayindesanni.com or WhatsApp +2347056667384. Purchase Link: https://paystack.com/buy/evidence-act-complete-annotation
______________________________________________________________________ “Enhance Legal Practice With Authoritative Reports” — Alexander Payne Offers Comprehensive Law Reports, Spanning Over A Century Of Nigerian Jurisprudence
Interested buyers are encouraged to place their orders and enquiries via:
0704 444 4777, 0704 444 4999, 0818 199 9888
Website: www.alexandernigeria.com
